Bain-backed Emcure Pharma's $234m India IPO draws $11bn in bids
BENGALURU (Reuters) -- India's Emcure Pharmaceuticals drew strong interest for its $234 million initial public offering as investors bet on its slate of women's health care and HIV treatments to drive growth in a high-margin market.